{"id":"W2890315255","doi":"10.1200/jco.2016.34.15_suppl.e15154","title":"Canadian experience managing dose intensity of regorafenib in relation to safety and clinical outcome in metastatic colorectal cancer patients.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Regorafenib; Internal medicine; Clinical endpoint; Adverse effect; Colorectal cancer; Hazard ratio; Oxaliplatin; Progression-free survival; Oncology; Chemotherapy; Surgery; Clinical trial; Gastroenterology; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002433697,0.0002039418,0.000385754,0.0007347185,0.0009803673,0.0008561246,0.0005652089,0.0003960491,0.002475689],"category_scores_gemma":[0.007096046,0.0001521933,0.0003385773,0.003425744,0.0004393738,0.0003779048,0.0005138086,0.0006062932,0.0002560418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01778788,"about_ca_system_score_gemma":0.01329359,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7029124,"about_ca_topic_score_gemma":0.8137366,"domain_scores_codex":[0.9985262,0.0003227046,0.0001008887,0.0001158249,0.000758127,0.0001761906],"domain_scores_gemma":[0.9941564,0.0009540336,0.001564086,0.0001230897,0.00228973,0.0009125923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002027838,0.0002083251,0.7380406,0.000420855,0.0001732578,0.0006191541,0.001352102,0.0009108083,0.0009717104,0.0004441269,0.01553333,0.239298],"study_design_scores_gemma":[0.0001433924,0.0006123813,0.9692321,0.0001380339,0.000109486,0.0009767215,0.0005637226,0.0004388432,0.0003659909,0.00008243026,0.02729468,0.00004219064],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9202816,0.03212302,0.0005989845,0.008226343,0.0001323952,0.0002924905,0.004082299,0.00006233696,0.03420056],"genre_scores_gemma":[0.9823644,0.01093833,0.0009235039,0.001419549,0.0001077785,0.00005040821,0.001711231,0.00002165922,0.002463061],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2970876,"threshold_uncertainty_score":0.5976744,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1102123649202364,"score_gpt":0.4719435139256971,"score_spread":0.3617311490054606,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}